Innova Captab Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
INNOVACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Innova Captab Limited reported consolidated revenue of ₹16,300.18 million for FY2026, up 31% from ₹12,436.76 million in FY2025. Profit after tax grew 9.9% to ₹1,409.17 million from ₹1,282.58 million. On a standalone basis, revenue increased 35% to ₹12,958.14 million, though PAT declined 6.5% to ₹836.92 million due to higher expenses. The statutory auditor B S R & Co. LLP issued an unmodified (clean) opinion on both standalone and consolidated results. The company operates in a single segment - drugs and pharmaceuticals. The Board also approved amendments to the Related Party Transactions policy.
Strong revenue growth of 31% on consolidated basis indicates solid business expansion, though standalone PAT decline raises concerns about cost efficiency at the parent level. Clean audit opinion removes any concerns about financial reporting quality.